Treatment strategy of EGFR-mutated non-small cell lung cancer

被引：1
|
作者：
Tanaka, Fumihiro [1 ]
Yoneda, Kazue [1 ]
Takenaka, Masaru [1 ]
Kuroda, Koji [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Surg Chest Surg 2, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2022年 / 14卷 / 03期
关键词：
OSIMERTINIB; PATIENT; MUTATIONS; SURGERY;
D O I：
10.21037/jtd-22-177
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：602 / 606
页数：5
相关论文
共 50 条
  • [41] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Fu, Kai
    Xie, Fachao
    Wang, Fang
    Fu, Liwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [42] Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
    Chevallier, Mathieu
    Tsantoulis, Petros
    Addeo, Alfredo
    Friedlaender, Alex
    CANCER GENOMICS & PROTEOMICS, 2020, 17 (05) : 597 - 603
  • [43] Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
    Kunimasa, Kei
    Kamada, Risa
    Oka, Toru
    Oboshi, Makiko
    Kimura, Madoka
    Inoue, Takako
    Tamiya, Motohiro
    Nishikawa, Tatsuya
    Yasui, Taku
    Shioyama, Wataru
    Nishino, Kazumi
    Imamura, Fumio
    Kumagai, Toru
    Fujita, Masashi
    JACC: CARDIOONCOLOGY, 2020, 2 (01): : 1 - 10
  • [44] Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non-Small Cell Lung Cancer
    Wang, Huaying
    Lin, Lie
    Liang, Chuqiao
    Pang, Jiaohui
    Yin, Jiani C.
    Zhang, Junli
    Shao, Yang
    Sun, Chengming
    Guo, Renhua
    JCO PRECISION ONCOLOGY, 2024, 8
  • [45] EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
    Madeddu, Clelia
    Donisi, Clelia
    Liscia, Nicole
    Lai, Eleonora
    Scartozzi, Mario
    Maccio, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [46] Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer
    Qureshi, Zaheer
    Altaf, Faryal
    Jamil, Abdur
    Siddique, Rimsha
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (01): : 44 - 54
  • [47] TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China
    Wang, Han
    Ma, Junrui
    Lu, Jiagui
    Wang, Yang
    Zhang, Binli
    Zhang, Hushan
    Peng, Hao
    BIOMARKERS IN MEDICINE, 2024, 18 (24) : 1123 - 1133
  • [48] Estrogen Metabolism in Patients with EGFR-Mutated and ALK-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Bodor, J. N.
    Treat, J.
    Krzizike, D. D.
    Zawislak, C. L.
    Vanderveer, L.
    Yulis, M.
    Chau, A.
    Ross, E. A.
    Andrews, A. J.
    Clapper, M. L.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S18 - S19
  • [49] Early dose reduction of osimertinib in advanced EGFR-mutated non-small cell lung cancer
    Ferreira, Marion
    Ebia, Matthew I.
    Reckamp, Karen L.
    ANTI-CANCER DRUGS, 2024, 35 (07) : 672 - 679
  • [50] Investigating osimertinib plus chemotherapy in EGFR-mutated advanced non-small cell lung cancer
    Spagnuolo, Alessia
    Gridelli, Cesare
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
12345